Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1442

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 6
Chunk 1442
---
) 
    $(24,149,060)
  
    Cancellation
    of common stock 
     -  
     -  
     (24,186) 
     (2) 
     2  
     -  
     -  
     -  
     -  
     - 
  
    Share-based
    compensation to vendors for services 
     -  
     -  
     24,717  
     3  
     5,683,053  
     -  
     -  
     5,683,056  
     -  
     5,683,056 
  
    Conversion
    of debt into common stock upon initial public offering 
     -  
     -  
     28,460  
     3  
     7,989,595  
     -  
     -  
     7,989,598  
     -  
     7,989,598 
  
    Conversion
    of debt into Series A Preferred Stock upon initial public offering 
     80,965  
     10,128,500  
     -  
     -  
     -  
     -  
     -  
     10,128,500  
     -  
     10,128,500 
  
    Reclassification
    of liability-classified warrants to equity-classified 
     -  
     -  
     -  
     -  
     838,748  
     -  
     -  
     838,748  
     -  
     838,748 
  
    Issuance of common stock pursuant to IPO, net of underwriting discounts, commissions, and deferred offering costs of $1,266,740 
     -  
     -  
     23,585  
     2  
     6,235,274  
     -  
     -  
     6,235,276  
     -  
     6,235,276 
  
    Issuance
    of common stock upon exercise of warrants 
     -  
     -  
     3,075  
     -